1.04 Dec 2023DirectorCurrent employeeRecommendCEO approvalBusiness outlookProsGood pay, until they lay you off.ConsConstant restructuring. Slow, bloated decision making even for big pharma.Show more
5.016 May 2026InternFormer internEast Hanover, NJRecommendCEO approvalBusiness outlookProspeople are friendly and easy to work withConsdaily commute takes longer than expectedShow moreHelpfulShare
2.025 June 2026Sales representativeCurrent employee, more than 10 yearsNew York, NYRecommendCEO approvalBusiness outlookProsGood Products to represent and many opportunities for advancementConsPoor culture, Poor Leadership. Restructuring every year or two.Show moreHelpfulShare